Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NovaBay Pharmaceuticals has appointed Thomas Paulson as its CFO. Mr Paulson will take over the CFO position from Jack O'Reilly, who will continue as senior vice president for corporate and business development.
Subscribe to our email newsletter
With the growth of the company and the range of target opportunities for NovaBay’s product candidates, the company said that its board has decided to separate the roles of CFO from that of senior vice president for corporate and business development.
Mr Paulson brings with him more than 35 years of financial and managerial experience, including working with publicly traded biotechnology and healthcare companies as well as for divisions of major healthcare corporations. Additionally, Mr Paulson has been a management consultant to several biotechnology and technology companies. Mr Paulson’s experience includes CFO positions at Avigen and Neurogen Corporation as well as financial positions at Ciba-Corning Diagnostics, Quidel Corporation and Abbott Laboratories.